Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates

L. Nathan Tumey(Binghamton University), Fengping Li(Pfizer (United States)), Brian Rago(Pfizer (United States)), Xiaogang Han(Amgen (United States)), Frank Loganzo(Pfizer (United States)), Sylvia Musto(Pfizer (United States)), Edmund I. Graziani(Pfizer (United States)), Sujiet Puthenveetil(AbbVie (United States)), Jeffrey Casavant(Pfizer (United States)), Kimberly Marquette(Pfizer (United States)), Tracey Clark(Pfizer (United States)), Jack Bikker(International Flavors & Fragrances (United States)), Eric M. Bennett(Pfizer (United States)), Frank Barletta(Pfizer (United States)), Nicole Piche‐Nicholas(Pfizer (United States)), Amy Tam(Pfizer (United States)), Christopher J. O’Donnell(Pfizer (United States)), Hans Peter Gerber(Maverick (United States)), Lioudmila Tchistiakova(Pfizer (United States))
The AAPS Journal
April 24, 2017
Cited by 66

Abstract


Related Papers

No related papers found

Powered by citation graph analysis